Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications View PDF
About Carly King
This author has yet to write their bio.Meanwhile lets just say that we are proud Carly King contributed a whooping 44 entries.
Entries by Carly King
Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing View PDF
AACR 2018. Multifunctional Biologics for Targeted T-cell Therapy Based on Humabody® VH Domains Poster view Poster
04-07 June 2018 BIO International Convention Peter Pack & Brian McGuinness to attend Boston